Cannabis tech company Akerna moves to raise $10 million as stock falls

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.

Struggling cannabis technology company Akerna is seeking to raise $10 million in capital in part to meet its debt obligations and other expenses.

The Denver-based company, which provides seed-to-sale tracking and other compliance software under MJ Freeway, said in a news release that it expects to generate the additional capital through a public offering of stock and warrants for 23 cents a unit.

Akerna stock, which trades on Nasdaq as KERN, fell 50% on the news to less than 15 cents a share as of midday Thursday.

The company said in a recent regulatory filing that its ability to continue as an ongoing concern depends on the success of a financial restructuring plan and its ability to raise additional capital.

Akerna recently cut 59 employees as part of its financial restructuring.

Business leaders need reliable industry data and in-depth analysis to make smart investments and informed decisions in these uncertain economic times.

Order your 2022 MJBiz Factbook, out now!

Featured Inside:
  • 200+ pages and 50 charts with key data points
  • State-by-state guide to regulations, taxes & opportunities
  • Segmented research reports for the marijuana + hemp industries
  • Accurate financial forecasts + investment trends


Stay ahead of the curve and avoid costly missteps in the rapidly evolving cannabis industry.

According to a news release, the public offering, which is expected to close around July 5, includes:

  • 29.4 million units that consist of 29.4 million shares of stock and warrants to purchase up to another 29.4 million shares of stock at 23 cents a share.
  • 14.1 million pre-funded units that consist of warrants that can be immediately exercised at less than 1 cent a share for 14.1 million shares of stock, plus warrants to purchase another 14.1 million shares of stock at 23 cents per share.

The offering also gives the underwriters a 45-day option to purchase additional stock and warrants totaling up to 13 million shares of stock.